![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 31/00 | (2006.01) | ||
A61K 31/167 | (2006.01) | ||
A61K 31/56 | (2006.01) | ||
A61P 11/06 | (2006.01) |
(11) | Patento numeris | 3107575 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15708991.3 |
Europos patento paraiškos padavimo data | 2015-02-20 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-12-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-01 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2015/016852 |
Data | 2015-02-20 |
(87) | Numeris | WO 2015/127229 |
Data | 2015-08-27 |
(30) | Numeris | Data | Šalis |
201461943019 P | 2014-02-21 | US | |
14306413 | 2014-09-15 | EP | |
201462077669 P | 2014-11-10 | US |
(72) |
PIROZZI, Gianluca , US
SKOBIERANDA, Franck , US
LI, Yongtao , US
GRAHAM, Neil , US
WEINSTEIN, Steven P. , US
|
(73) |
Sanofi Biotechnology ,
54 rue La Boétie, 75008 Paris,
FR
Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US |
(54) | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST |
METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST |